Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D. Lynch, Cynthia Levy, Roger W. Chapman et al.|Clinical Gastroenterology and Hepatology|2019Cited by 104
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitisMaryam Yazdanfar, Christopher L. Bowlus, Cynthia Levy et al.|Hepatology Communications|2024Cited by 7